Literature DB >> 21723920

Effects of chronic immobilization stress on anxiety-like behavior and basolateral amygdala morphology in Fmr1 knockout mice.

M Qin1, Z Xia, T Huang, C B Smith.   

Abstract

Several lines of clinical evidence support the idea that fragile X syndrome (FXS) may involve a dysregulation of hypothalamic-pituitary-adrenal axis function [Wisbeck et al. (2000) J Dev Behav Pediatr 21:278-282; Hessl et al. (2002) Psychoneuroendocrinology 27:855-872]. We had tested this idea in a mouse model of FXS (Fmr1 KO) and found that the hormonal response to acute stress was similar to that of wild-type (WT) mice [Qin and Smith (2008) Psychoneuroendocrinology 33:883-889]. We report here responses to chronic stress (CS) in Fmr1 KO mice. Following restraint for 120 min/d, 10 consecutive days, we assessed dendrite and spine morphology in basolateral amygdala (BLA). We also monitored behavior in an elevated plus maze (EPM) and the hormonal response to this novel spatial environment. After CS, mice of both genotypes underwent adrenal hypertrophy, but effects were greater in WT mice. Behavior in the EPM indicated that only WT mice had the expected increase in anxiety following CS. Serum corticosterone and adrenocorticotropic hormone (ACTH) levels were both increased following the spatial novelty of EPM, and there were no differences between genotypes in the hormonal responses. BLA dendritic branching increased proximal to the soma in WT, but in Fmr1 KO mice branching was unaffected close to the soma and slightly decreased at one point distal to the soma. Similarly, spine density on apical and basal dendrites increased in WT but decreased in Fmr1 KO mice. Spine length on apical and basal dendrites increased in WT but was unaffected in Fmr1 KO mice. These differences in behavioral response and effects on neuron morphology in BLA suggest a diminished adaptive response of Fmr1 KO mice. Published by Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21723920      PMCID: PMC3183352          DOI: 10.1016/j.neuroscience.2011.06.047

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  41 in total

Review 1.  The emotional brain, fear, and the amygdala.

Authors:  Joseph LeDoux
Journal:  Cell Mol Neurobiol       Date:  2003-10       Impact factor: 5.046

2.  Weight loss in rats exposed to repeated acute restraint stress is independent of energy or leptin status.

Authors:  Ruth B S Harris; Tiffany D Mitchell; Jacob Simpson; Stephen M Redmann; Bradley D Youngblood; Donna H Ryan
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2002-01       Impact factor: 3.619

3.  Cortisol and social stressors in children with fragile X: a pilot study.

Authors:  J M Wisbeck; L C Huffman; L Freund; M R Gunnar; E P Davis; A L Reiss
Journal:  J Dev Behav Pediatr       Date:  2000-08       Impact factor: 2.225

4.  Increased rates of cerebral glucose metabolism in a mouse model of fragile X mental retardation.

Authors:  Mei Qin; Julia Kang; Carolyn Beebe Smith
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-11       Impact factor: 11.205

5.  RNA cargoes associating with FMRP reveal deficits in cellular functioning in Fmr1 null mice.

Authors:  Kevin Y Miyashiro; Andrea Beckel-Mitchener; T Patrick Purk; Kevin G Becker; Tanya Barret; Lei Liu; Salvatore Carbonetto; Ivan Jeanne Weiler; William T Greenough; James Eberwine
Journal:  Neuron       Date:  2003-02-06       Impact factor: 17.173

6.  Recovery after chronic stress fails to reverse amygdaloid neuronal hypertrophy and enhanced anxiety-like behavior.

Authors:  A Vyas; A G Pillai; S Chattarji
Journal:  Neuroscience       Date:  2004       Impact factor: 3.590

7.  Involvement of the amygdala GABAergic system in the modulation of memory storage.

Authors:  J D Brioni; A H Nagahara; J L McGaugh
Journal:  Brain Res       Date:  1989-05-15       Impact factor: 3.252

8.  Cortisol and behavior in fragile X syndrome.

Authors:  D Hessl; B Glaser; J Dyer-Friedman; C Blasey; T Hastie; M Gunnar; A L Reiss
Journal:  Psychoneuroendocrinology       Date:  2002-10       Impact factor: 4.905

9.  Tissue plasminogen activator in the amygdala is critical for stress-induced anxiety-like behavior.

Authors:  Robert Pawlak; Ana Maria Magarinos; Jerry Melchor; Bruce McEwen; Sidney Strickland
Journal:  Nat Neurosci       Date:  2003-02       Impact factor: 24.884

10.  The endogenous cannabinoid system controls extinction of aversive memories.

Authors:  Giovanni Marsicano; Carsten T Wotjak; Shahnaz C Azad; Tiziana Bisogno; Gerhard Rammes; Maria Grazia Cascio; Heike Hermann; Jianrong Tang; Clementine Hofmann; Walter Zieglgänsberger; Vincenzo Di Marzo; Beat Lutz
Journal:  Nature       Date:  2002-08-01       Impact factor: 49.962

View more
  27 in total

Review 1.  The trouble with spines in fragile X syndrome: density, maturity and plasticity.

Authors:  C X He; C Portera-Cailliau
Journal:  Neuroscience       Date:  2012-04-20       Impact factor: 3.590

2.  Mild blast-related TBI in a mouse model alters amygdalar neurostructure and circuitry.

Authors:  Whitney A Ratliff; Ronald F Mervis; Bruce A Citron; Brian Schwartz; Vardit Rubovitch; Shaul Schreiber; Chaim G Pick
Journal:  Exp Neurol       Date:  2019-01-31       Impact factor: 5.330

3.  Stress-induced grey matter loss determined by MRI is primarily due to loss of dendrites and their synapses.

Authors:  Mustafa S Kassem; Jim Lagopoulos; Tim Stait-Gardner; William S Price; Tariq W Chohan; Jonathon C Arnold; Sean N Hatton; Maxwell R Bennett
Journal:  Mol Neurobiol       Date:  2012-11-09       Impact factor: 5.590

4.  Early social enrichment rescues adult behavioral and brain abnormalities in a mouse model of fragile X syndrome.

Authors:  Diego Oddi; Enejda Subashi; Silvia Middei; Luigi Bellocchio; Valerie Lemaire-Mayo; Manuel Guzmán; Wim E Crusio; Francesca R D'Amato; Susanna Pietropaolo
Journal:  Neuropsychopharmacology       Date:  2015-03-13       Impact factor: 7.853

5.  Elevated tph2 mRNA expression in a rat model of chronic anxiety.

Authors:  Nina C Donner; Philip L Johnson; Stephanie D Fitz; Karen E Kellen; Anantha Shekhar; Christopher A Lowry
Journal:  Depress Anxiety       Date:  2012-04       Impact factor: 6.505

6.  Brain neuroplastic changes accompany anxiety and memory deficits in a model of complex regional pain syndrome.

Authors:  Maral Tajerian; David Leu; Yani Zou; Peyman Sahbaie; Wenwu Li; Hamda Khan; Vivian Hsu; Wade Kingery; Ting Ting Huang; Lino Becerra; J David Clark
Journal:  Anesthesiology       Date:  2014-10       Impact factor: 7.892

Review 7.  From FMRP function to potential therapies for fragile X syndrome.

Authors:  Ferzin Sethna; Changjong Moon; Hongbing Wang
Journal:  Neurochem Res       Date:  2013-12-18       Impact factor: 3.996

8.  Behavioral analysis of male and female Fmr1 knockout mice on C57BL/6 background.

Authors:  Qi Ding; Ferzin Sethna; Hongbing Wang
Journal:  Behav Brain Res       Date:  2014-06-02       Impact factor: 3.332

9.  Effects of stress on AMPA receptor distribution and function in the basolateral amygdala.

Authors:  G W Hubert; C Li; D G Rainnie; E C Muly
Journal:  Brain Struct Funct       Date:  2013-05-05       Impact factor: 3.270

10.  Somatostatin analogue, Octreotide, improves restraint stress-induced liver injury by ameliorating oxidative stress, inflammatory response, and activation of hepatic stellate cells.

Authors:  Neven Makram Aziz; Merhan Mamdouh Ragy; Sabreen Mahmoud Ahmed
Journal:  Cell Stress Chaperones       Date:  2018-08-14       Impact factor: 3.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.